Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 1, Issue 3, 1998, Pages 134-143

  Penson, D F ^a   Litwin, M S ^a,f   Lubeck, D P ^b,c   Flanders, S ^d   Pasta, D J ^c   Carroll, P R ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Technology Assessment Group   (United States)

^d TAP Holdings Inc   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Outcomes; Patient assessment; Predictors; Prostate cancer; Quality of life

Indexed keywords

EID: 0000429629     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500228     Document Type: Article

References (42)

1. Altwein J et al. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology 1997 49: 66-76.
2. Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific modulo supplementing the EORTC QLQ-C30. Qual Life Res 1996 5: 212-222.
3. Litwin MS et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995 273: 129-135.
4. Lubeck DP et al. The CaPSURE Database: A Methodlogy for Clinical Practice and Research in Prostate Cancer. Urology 1996 48: 773-777.
5. Lubeck D et al. Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acq Imm Defic Synd 1993 6: 478-484.
6. Fries J, Spitz P, Young D. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982 9: 789-793.
7. Pryor DB et al. Clinical data bases: accomplishments and unrealized potential. Med Care 1985 23: 623-647.
8. Beard CJ et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997 15: 223-229.
9. Beckendorf V et al. Changes in sexual function after radiotherapy treatment of prostate cancer. Br J Urol 1996 77: 118-123.
10. Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Br J Urol 1995 75: 48-53.
11. Caffo O, Fellin G, Graffer U, Luciani L. Assessment of quality of life after radical radiotherapy for prostate cancer. Br J Urol 1996 78: 557-563.
12. Fowler FJ, Jr. et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995 45: 1007-1013.
13. Lim AJ et al. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995 154: 1420-1425.
14. Pedersen KV, Carlsson P, Rahmquist M, Varenhorst E. Quality of life after radical retropubic prostatectomy for carcinoma of the prostate. Eur Urol 1993 24: 7-11.
15. Roach M 3rd, Chinn DM, Holland J, Clarke M. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Rad Oncol Biol Phys 1996 35: 869-874.
16. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 1997 79: 197719-86.
17. Krongrad A et al. Marriage and mortality in prostate cancer. J Urol 1996 156: 1696-1700.
18. Kornblith AB et al. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer 1994 73: 2791-2802.
19. Jonler M et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol 1995 75: 651-655.
20. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item Health Survey 1.0. Health Econ 1993 2: 217-227.
21. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30: 473-483.
22. Stewart AL et al. Functional status and well-being of patients with chronic conditions. JAMA 1989 262: Results from the Medical Outcomes. 907-913.
23. Lubeck D, Litwin M, Henning J, Carroll P. Measurement of health-related quality of life in men with prostate cancer: Data from the CaPSURE database. Qual Life Res 1997 6: 385-392.
24. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II: Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993 31: 31-40.
25. Parkerson GR, Jr. et al. Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med Care 1993 31: 629-639.
26. Long SA et al. Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope 1996 106: 1084-1088.
27. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health care status and quality of life. Med Care 1989 27: (suppl): S217-S232.
28. Yellen SB, Cella DF. Someone to live for: social well-being, parenthood status, and decision-making in oncology. J Clin Oncol 1995 13: 1255-1264.
29. Perneger TV, Etter JF, Rougemont A. Switching Swiss enrollees from indemnity health insurance to managed care: the effect on health status and stisfaction with care. Am J Pub Health 1996 86: 388-393.
30. Clement DG, Retchin SM, Brown RS, Stegall MH. Access and outcomes of elderly patients enrolled in managed care. JAMA 1994 271: 1487-92.
31. Jonler M et al. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Urology 1994 44: 876-882.
32. Ljung G et al. Adverse effects after radical external beam radiotherapy of localized prostatic adenocarcinoma using two-dimensional dose-planning and a limited field technique. Acta Oncol 1996 35: 445-450.
33. Watkins-Bruner D et al. RTOG's first quality of life study - RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Rad Oncol Biol Phys 1995 33: 901-916.
34. Krongrad A et al. Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer. J Urol 1997 157: 534-538.
35. Mazur DJ, Merz JF. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer. J Am Geriatr Soc 1996 44: 934-937.
36. Sen M. Communication with cancer patients. The influence of age, gender, education, and health insurance status. Ann NY Acad Sci 1997 809: 514-524.
37. Graling PR, Grant JM. Demographics and patient treatment choice in stage I breast cancer. AORN J 1995 62: 376-384.
38. Ware JE SF-36 Health Survey: Manual and Interpretation Guide. 2nd edn. 1997 The Health Institute: Boston, MA.
39. Dugan JA et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 1996 275: 288-294.
40. Schag CA et al. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res 1994 3: 127-141.
41. van Andel G, Kurth KH, de Haes JCJM. Quality of life in patients with prostatic carcinoma: a review and results of a study with N + disease. Urol Res 1997 25: S79-S88.
42. Fowler FJ, Jr. et al. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996 14: 2258-2265.